Patents by Inventor Frederick C. Copp

Frederick C. Copp has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5049637
    Type: Grant
    Filed: December 7, 1989
    Date of Patent: September 17, 1991
    Assignees: Monash University, Australasian Drug Development Limited
    Inventors: Frederick C. Copp, Alan L. A. Boura, William R. Jackson, John D. Cullen
  • Patent number: 4847249
    Abstract: 3,5-Diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine isethionate is provided. This salt has high water solubility and thus advantageously allows parenteral administration in the form of a sterile aqueous solution suitable for injection.
    Type: Grant
    Filed: May 29, 1987
    Date of Patent: July 11, 1989
    Inventors: David A. Sawyer, Frederick C. Copp
  • Patent number: 4572913
    Abstract: Compounds of formula (I) ##STR1## inhibit both the cyclo-oxygenase and lipoxygenase pathways of arachidonic acid oxygenation and are useful in medicine as, e.g., anti-inflammatory and anti-asthmatic agents.The compounds may be administered as the raw chemical or in association with a carrier as a pharmaceutical formulation.The compounds may be prepared by methods analogous to those known in the art, e.g., by the method of Duffin and Kendall in J. Chem. Soc. (1954), 408-415, or by other methods.
    Type: Grant
    Filed: December 15, 1981
    Date of Patent: February 25, 1986
    Assignee: Burroughs Wellcome Co.
    Inventors: Frederick C. Copp, Albert G. Caldwell, David Collard
  • Patent number: 4564684
    Abstract: Heterocyclic compounds of formula (I) and acid addition salts thereof inhibit arachidonic acid oxygenation and are useful in medicine, for example as anti-inflammatory agents. ##STR1## The compounds of formula (I) may be prepared by any method analogous to those known in the art, for example by the method of G. F. Duffin and J. D. Kendall in J. Chem. Soc. (1954), 408-415. When used in medicine, the compounds of formula (I) may be administered as the compound alone or as a pharmaceutical formulation together with a pharmaceutically acceptable carrier.
    Type: Grant
    Filed: May 23, 1984
    Date of Patent: January 14, 1986
    Inventors: Frederick C. Copp, Albert G. Caldwell, David Collard
  • Patent number: 4556671
    Abstract: Heterocyclic compounds of formula (I) ##STR1## and their acid addition salts, when administered topically, exhibit anti-inflammatory activity and do not produce the side-effects associated with the administration of certain other anti-inflammatories. The compounds of formula (I) may be administered topically as the compound alone or in a suitable topical pharmaceutical formulation.
    Type: Grant
    Filed: May 22, 1981
    Date of Patent: December 3, 1985
    Assignee: Burroughs Wellcome Co.
    Inventors: Frederick C. Copp, Kenneth E. Eakins
  • Patent number: 4465685
    Abstract: Compounds of formula (I) ##STR1## inhibit both the cyclo-oxygenase and lipoxygenase pathways of arachidonic acid oxygenation and are useful in medicine as, e.g., anti-inflammatory and anti-asthmatic agents.The compounds may be administered as the raw chemical or in association with a carrier as a pharmaceutical formulation.The compounds may be prepared by methods analogous to those known in the art, e.g. by the method of Duffin and Kendall in J. Chem. Soc. (1954), 408-415, or by other methods.
    Type: Grant
    Filed: December 15, 1981
    Date of Patent: August 14, 1984
    Assignee: Burroughs Wellcome Co.
    Inventors: Frederick C. Copp, Albert G. Caldwell, David Collard
  • Patent number: 4414223
    Abstract: 1-Phenoxyalkyl- and 1-anilinoalkyl imidazolines, methods for the preparation thereof, the use thereof as intermediates and pesticides and pesticidal formulations containing such compounds.
    Type: Grant
    Filed: May 18, 1981
    Date of Patent: November 8, 1983
    Assignee: Burroughs Wellcome Co.
    Inventors: Frederick C. Copp, Peter T. Roberts, Alexander D. Frenkel, David Collard
  • Patent number: 4277498
    Abstract: Glycinamides of formula (1):NH.sub.2 CH.sub.2 CONHE (1)wherein E has seven to nine carbon atoms and is branched alkyl, alkylcycloalkyl or cycloalkylalkyl or their acid addition salts, methods of preparing them, pharmaceutical compositions containing them and their use in medicine as anti-depressants.
    Type: Grant
    Filed: July 23, 1979
    Date of Patent: July 7, 1981
    Assignee: Burroughs Wellcome Co.
    Inventors: Frederick C. Copp, David Collard, Clive V. Denyer
  • Patent number: 4226876
    Abstract: Compounds of formula (I): ##STR1## wherein Ar is an unsubstituted or mono-, di or tri-substituted phenyl radical in which the substituents are the same or different and are selected from alkyl, alkoxy, halogen, hydroxy, cyano, amino, trifluoromethyl or nitro and in which any two adjacent carbon atoms on the phenyl ring may optionally be joined by a carbon chain having 3 or 4 carbon atoms;X.sup.1 is O or NH;R.sup.1 and R.sup.2 are the same or different and are hydrogen or alkyl; andZ is a group SO.sub.n R.sup.8 or a group ##STR2## in which X.sup.2 is O, S or NR.sup.4 ; R.sup.3 is alkyl, aryl, alkyloxy, aryloxy or NR.sup.5 R.sup.6 ;R.sup.4 is alkyl, aryl, alkyloxy, aryloxy, alkylthio, arylthio or NR.sup.5 R.sup.6 ;R.sup.5 and R.sup.6 are the same or different and are hydrogen, alkyl, aryl, COR.sup.7 or SO.sub.2 R.sup.7 ;R.sup.7 is alkyl, aryl, alkoxy or aryloxy;n is 1 or 2;R.sup.8 is alkyl, aryl or NR.sup.9 R.sup.10 ; andR.sup.9 and R.sup.
    Type: Grant
    Filed: December 11, 1978
    Date of Patent: October 7, 1980
    Assignee: Burroughs Wellcome Co.
    Inventors: Frederick C. Copp, Peter T. Roberts, Alexander D. Frenkel, David Collard